Previous Page  172 / 320 Next Page
Information
Show Menu
Previous Page 172 / 320 Next Page
Page Background

576

I direct a critical care pharmacist PGY-2 residency

program and monitor the progress of the resident and

interactions with other preceptors in our health-system.

I participate in multiprofessional journal club discussions,

case conferences and quality review meetings. Like other

professionals I seek to maintain a role in scholarly contri-

butions to the literature and to maintain competency

and be current with the burgeoning literature. As a Board

Certified Critical Care Pharmacist, I have a requirement

for continuing education and maintenance of certifica-

tion, and as a licensed pharmacist I must also maintain

continuing education.

FUTURE

While the clinical pharmacy programs are in various stages

of development globally the need for specialists with a broad

focus on medications and their optimal use is universal. The

American College of Clinical Pharmacists has supported

these training programs and provided education to indi-

viduals and groups. Their publications are used for prepara-

tion and maintenance of board certification by pharmacists

worldwide. This outreach is expected to continue, as more

partners are engaged and more pharmacists and their

multiprofessional teams recognize the opportunities for

clinical pharmacists to improve patient care.

BIBLIOGRAPHIC REFERENCES

1.

http://www.accp.com/about/clinicalPharmacyDefined.aspx

,

accessed 3/25/16

2. Viswanathan M, Kahwati LC, Golin CE, et al. Medication

therapy management interventions in outpatient settings. A

systematic review and meta-analysis. JAMA Intern Med 2015;

175: 76-87.

3. Doherty RB, Crowley RA, for the Health and Public Policy

Committee of the American College of Physicians. Principles

supporting dynamic clinical care teams: An American College

of Physicians position paper. Ann Intern Med 2013; 159:

620-626.

4. Executive summary: Collaboration in practice: implementing

team-based care. American College of Obstetricians and

Gynecologists. Obstet Gynecol 2016; 127: 612-617.

5. Proia KK, Thota AB, Gibril JN, et al. Team-based care and

improved blood pressure control. A community guide

systematic review. Am J Prev Med 2014; 47:86-99

6. Joint Commission of Pharmacy Practitioners. Pharmacist

patient care process.

https://www.pharmacist.com/sites/

default/files/files/PatientCareProcess.pdf, Accessed 3/25/16

7. h t t p : / / www . a c c p . c om / d o c s / p o s i t i o n s / g u i d e l i n e s /

standardsofpractice.pdf Acccessed 4/18/16

8.

http://www.ashp.org/DocLibrary/Accreditation/Newly-

approved-PGY1-Standard-September-2014.pdf, Accessed

3/25/2016

9.

http://www.ashp.org/menu/PracticePolicy/ResourceCenters/

Residency/PGY2-Residencies, Accessed 3/25/16

10. Ruis I, Jiron M, Pinilla E, Paulos C, Pezzani M, Rubio B, et al.

Pharmaceutical care education at the University of Chile. Am J

Pharmaceut Ed 2003; 66:144-147

11. American College of Clinical Pharmacy, McBane SE, Dopp AL,

Abe A, Benavides S, Chester EA, et al. Collaborative drug therapy

The author declares no conflicts of interest in relation to this article.

management and comprehensive medication management-

2015. Pharmacotherapy 2015; 35:e39-e50.

12. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality

assessment of a collaborative approach for decreasing drug-

related morbidity and achieving therapeutic goals. Arch Intern

Med 2003; 163: 1813-1820

13.

http://www.bpsweb.org/Accessed

3/25/16

14. Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, Herrier RN,

Hall-Lipsy E, et al. US pharmacists’ effect as team members on

patient care. Med Care 2010; 10:923-933.

15. Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on

adverse drug events and medication errors in outpatients with

cardiovascular disease. Arch Intern Med 2009; 169:757-763.

16. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT.

Pharmacist care of patients with heart failure. Arch Intern Med

2008; 168:687-64.

17. Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page

RL, et al. The role of the clinical pharmacist in the care of

patients with cardiovascular disease. J Am Coll Cardiol 2015;

66:2129-2139.

18. Brandis R, Rodgers GP, Handberg EM. President’s page: team-

based care: a solution for our health care delivery challenges. J

Am Coll Cardiol 2011; 57:1123-1125.

19. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA.

Pharmacists on rounding teams reduce preventable adverse

drug events in hospital general medicine units. Arch Intern

Med 2003; 163:2014-2018.

20. Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and

potential adverse events prevented by intervention of a critical

care pharmacist. Am J Health-Syst Pharm 2007; 64:2483-

2487.

21. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical

[REV. MED. CLIN. CONDES - 2016; 27(5) 571-577]